Tuberous Sclerosis Skin Lesions Improved on EverolimusThe Oncology ReportPRAGUE – Everolimus significantly improved the skin lesions of tuberous sclerosis complex in two phase-III clinical trials, Dr. Sergiusz Jozwiak reported at the annual congress …

Six Late-breaking Abstracts Selected for Oral Presentation at The Liver Meeting®Sacramento BeeAfter liver transplantation, one of the main complications is renal failure due to tacrolimus-based therapy to prevent rejection. The final results of a rand…

TCTMDBoston Scientific receives CE mark for everolimus-eluting coronary stentEquities.comNov 02, 2012 (Datamonitor via COMTEX) — Boston Scientific Corporation, a medical device company, has received CE mark approval for the SYNERGY everolimus-eluting …

Boston Scientific Boosts Portfolio – Analyst BlogNASDAQBoston Scientific 's ( BSX ) coronary stent portfolio was boosted with the CE Mark approval of its Synergy everolimus-eluting platinum chromium stent. The product features everolimus drug coati…

Medgadget.comBoston Scientific's SYNERGY Everolimus-Eluting Stent Cleared in EuropeMedgadget.comBoston Scientific received CE Mark approval and is gearing up for a limited European market release of its SYNERGY Everolimus-Eluting Platinum Chromium …

Steroids speed sore throat recoveryPulseThe Cochrane analysis of results from eight randomised trials of almost 750 adults and children showed those taking corticosteroids were three times more likely to have no pain 24 hours later. The data showed tha…

Genetic testing changes breast cancer focusThe Augusta ChronicleTwo appear to target the HER2 marker but one, called everolimus, is aimed at breast cancers without HER2 but that are estrogen-positive and whose disease has spread, Samuel said. Many time…

New focus on molecular targets changes focus on breast and other cancersThe Augusta ChronicleTwo appear to target the HER2 marker but one, called everolimus, is aimed at breast cancers without HER2 but that are estrogen-positive and whose disease has s…

Telaprevir therapy required tacrolimus dose reduction in liver transplant …HealioLAS VEGAS — Telaprevir affected the metabolism of tacrolimus in liver transplant recipients with HCV, but may be an effective treatment for this population, according …

Boston Scientific reports positive data from long coronary lesions trialEquities.comOct 26, 2012 (Datamonitor via COMTEX) — Boston Scientific Corporation has reported clinical endpoint data from the PLATINUM Long Lesion trial, demonstrating positive o…